 |
|
| Fresenius
Polysulfone®具有 |
|
- 無法超越的生物相容性
- 卓越的清除效能
- 獨特的透析膜構造可有效防止內毒素及CIS的通過
- 獨特In-Line蒸氣消毒-無殘餘物、安全性佳
- 完整的人工腎臟系列產品可滿足不同臨床需求
|
|
| |
|
| Fx-class helixone®具有 |
|
- 專利奈米(NCS™)技術研發獨一無二的合成膜helixone®
- 改善氧化壓力
- 減少發炎反應
- 保護血管內皮細胞
- 降低透析病人新血管疾病風險 |
|
| |
|
| Fresenius Polysulfone®
Low-Flux HPS Dialysers |
|
| |
F4HPS |
F5HPS
|
F6HPS |
F7HPS |
F8HPS |
F10HPS |
| Ultrafiltration
coefficeint(ml/h-mmHg) |
4.3 |
6.2 |
8.5 |
9.8 |
11.1 |
18 |
| Clearances:(ml/min) |
Urea |
160/190/207 |
174/217/240 |
183/237/268 |
186/240/273 |
188/242/278 |
193/258/300 |
| QB=200/300/400
ml/min |
Creatinene |
131/155/164 |
152/182/197 |
167/206/228 |
172/214/240 |
175/220/248 |
180/226/255 |
| Phosphate |
95/115/122 |
120/145/158 |
140/170/190 |
150/182/202 |
156/190/210 |
170/210/233 |
| Vitamin
B12 |
50/56/58 |
65/74/78 |
80/92/98 |
90/105/112 |
102/118/125 |
125/142/151 |
Effective
surface are (㎡) |
0.7 |
1.0 |
1.3 |
1.6 |
1.8 |
2.4 |
Priming
volume, blood (ml) |
42 |
6.3 |
82 |
98 |
110 |
138 |
Membrane |
Low-Flux High Performance
Fresenius Polysulfone® |
F4HPs-F8HPS:
wall thickness 40μm/inner diameter 200 μm
F10HPS: wall thickness 35 μm/inner diameter 185 μm |
Sterilisation
method |
In-Line Steam |
|
| |
|
| Fresenius Polysulfone®
Low-Flux Dialysers |
|
| |
F3 |
F4
|
F5 |
F6 |
F7 |
F8 |
| Ultrafiltration
coefficeint(ml/h-mmHg) |
1.7 |
2.8 |
4.0 |
5.5 |
6.4 |
7.5 |
| Clearances:(ml/min) |
Urea |
125* |
155/183/198 |
170/206/225 |
180/222/244 |
184/236/265 |
186/240/275 |
| QB=200/300/400
ml/min |
Creatinene |
95* |
128/145/152 |
149/175/186 |
164/194/208 |
169/210/235 |
172/216/245 |
| *QB=200
ml/min |
Phosphate |
50* |
78/88/93 |
103/115/120 |
123/145/156 |
132/155/168 |
138/165/180 |
| Vitamin
B12 |
20* |
32/54/35 |
45/47/48 |
60/62/63 |
68/72/74 |
76/82/86 |
| Effective
surface are (㎡) |
0.4 |
0.7 |
1.0 |
1.3 |
1.6 |
1.8 |
| Priming
volume, blood (ml) |
28 |
42 |
63 |
82 |
98 |
110 |
| Membrane |
Low-Flux Fresenius Polysulfone®
(wall thickness 40μm/inner diameter 200 μm)
|
| Sterilisation
method |
ETO Sterilisation |
|
